Back to News
Market Impact: 0.15
Study Unveils ‘Plug-and-Play’ CAR T Technology Designed to Adapt as Cancer Changes
Source: Business Wire
Healthcare & BiotechTechnology & Innovation
City of Hope announced an adaptable, “plug-and-play” CAR T-cell technology designed to be updated after treatment as tumors evolve. The development could improve the durability and flexibility of CAR T therapies, but the release provided no clinical-efficacy, regulatory, or commercial data.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
More News
- How the US midterm elections reflected resistance to data centres
- Elon Musk once said the Cybertruck would be Tesla’s ‘best product ever.’ Now he’s winding down production
- AI Party isn't Ending Because Of The Blue Wave Says Ives
- SoftBank, ABB consider China carve-out to rescue $5.4bn robotics deal
- A ‘geologic freak’ called the Smackover may end America’s lithium dependence on China, and Big Oil is already there
- AI’s Grip on Financial Markets Was Never Clearer on the Way Down